
RLS-2202 Phase 1a Trial Advances to Cohort 2
Filed with ASX ·
6ix is reading this filing.
Earlier from Patrys
- Investor Presentation
- Investor Webinar
- Appendix 4E Variance Report
- First Participants Dosed in RLS-2202 Phase 1A Clinical Trial
- PAB Establishes Clinical Advisory Committee
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys